Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
Author(s):
Landewe, R.; Braun, J.; Deodhar, A.; Dougados, M.; Maksymowych, W.P.; Mease, P.J.; Reveille, J.D.; Rudwaleit, M.; Heijde, D. van der; Stach, C.; Hoepken, B.; Fichtner, A.; Coteur, G.; Longueville, M. de; Sieper, J.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 1, p. 39-47
